Odyssey Therapeutics, Inc.(ODTX:US)
Market Cap$809.98M
Key Metrics
Price$17.17
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$41.69M
Total Assets$269.79M
Net Assets-$488.28M
Total Debt$27.11M
Key Metrics
Price$17.17
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$41.69M
Total Assets$269.79M
Net Assets-$488.28M
Total Debt$27.11M
Financials
| Name | Mar 31, 2026 | Dec 31, 2024 |
|---|---|---|
Revenue | $0 | $1.76M |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $39.67M | $38.88M | |
| Research and Development | $32.32M | $31.48M |
| Selling, General, and Administrative | $7.35M | $7.4M |
| Other Operating Expenses | - | - |
Operating Income | -$39.67M | -$37.12M |
| $1.47M | $1.24M | |
| Non-Operating Interest Income | $1.71M | $1.77M |
| Non-Operating Interest Expense | $10K | $4K |
| Other Income/Expense | -$226K | -$533K |
Income Before Tax | -$38.2M | -$35.89M |
Income Tax | $63K | $47K |
Net Income | -$38.26M | -$35.93M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$38.26M | -$35.93M |
Shares Outstanding (Basic) | 47.17M | - |
Shares Outstanding (Diluted) | 47.17M | - |
EPS (Basic) | -$0.81 | - |
EPS (Diluted) | -$0.81 | - |
EBIT | -$38.19M | -$35.88M |
EBITDA | -$36.91M | -$34.21M |